BAHARAFF ALLEN enters GALMED PHARMACEUTICALS LTD. with 308.62K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Restricted Share Units
DirectRestricted Share Units
DirectOrdinary Shares
DirectRestricted Share Units
DirectOrdinary Shares
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Restricted Share Units | 8.89K | Direct |
| Restricted Share Units | 96.67K | Direct |
| Ordinary Shares | 103.05K | Direct |
| Restricted Share Units | 100K | Direct |
| Ordinary Shares | 18.00 | Indirect |
| Total | 308.62K | 308.60K direct·18.00 indirect |
Options to Purchase Ordinary Shares
DirectUnderlying shares
1.22K
Shares owned
N/A
Exercise price
921.60
Expiration
—
Exercise window
—
Options to Purchase Ordinary Shares
DirectUnderlying shares
1.22K
Shares owned
N/A
Exercise price
599.40
Expiration
—
Exercise window
—
Options to Purchase Ordinary Shares
DirectUnderlying shares
1.22K
Shares owned
N/A
Exercise price
2080.80
Expiration
—
Exercise window
—
Options to Purchase Ordinary Shares
DirectUnderlying shares
1.80K
Shares owned
N/A
Exercise price
0.002
Expiration
—
Exercise window
—
Underlying
5.47K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options to Purchase Ordinary Shares Direct | Ordinary Shares | 921.60 | — | — | 1.22K | N/A |
| Options to Purchase Ordinary Shares Direct | Ordinary Shares | 599.40 | — | — | 1.22K | N/A |
| Options to Purchase Ordinary Shares Direct | Ordinary Shares | 2080.80 | — | — | 1.22K | N/A |
| Options to Purchase Ordinary Shares Direct | Ordinary Shares | 0.002 | — | — | 1.80K | N/A |
| Total | 5.47K | 0.00 | ||||